Particle.news
Mitochondrial Diseases Batten Disease Diagnosis Amyloidosis Progressive Supranuclear Palsy Fibrodysplasia Ossificans Progressiva Creatine Transporter Deficiency Chediak-Higashi Syndrome Genetic Conditions Mitochondrial Disorders Prevalence Nephrogenic Systemic Fibrosis Motor Neurone Disease Aplastic Anaemia Multicentric Carpotarsal Osteolysis Langerhans Cell Histiocytosis Cancer Barth Syndrome Wilkie Syndrome Hereditary Angioedema Neuroblastoma Sanfilippo Syndrome Mitochondrial Disease Surgical Procedures Xeroderma Pigmentosum (XP) Congenital Diseases Drug Discovery Addison's Disease Neurodegenerative Diseases Epidermolysis Bullosa Metabolic Disorders
The agency based its decision on gains in knee‑extensor strength judged reasonably likely to signal real‑world benefit.
